Race as an outcome predictor after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

Urology

Volumn 60, Issue 4, 2002, Pages 670-674

  Freedland, Stephen J ^a   Amling, Christopher L ^b   Dorey, Frederick ^a   Kane, Christopher J ^c   Presti Jr, Joseph C ^d   Terris, Martha K ^d,e   Aronson, William J ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CAPSULE FILLING; CAUCASIAN; CLINICAL FEATURE; DATA ANALYSIS; DATA BASE; HEALTH CARE; HEALTH CENTER; HEALTH STATUS; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; ONSET AGE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATECTOMY; RACE; RACE DIFFERENCE; RATING SCALE; RETROSPECTIVE STUDY; SEMINAL VESICLE; TIME; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOPSY, NEEDLE; CALIFORNIA; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DATABASES; HEALTH CARE SURVEYS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MULTIVARIATE ANALYSIS; PALPATION; PROBABILITY; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0036774936     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01847-2     Document Type: Article

References (17)

1. Fowler J.E. Jr, Terrell F. Survival in blacks and whites after treatment for localized prostate cancer. J Urol. 156:1996;133-136.
2. Sohayda C.J., Kupelian P.A., Altsman K.A., et al. Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol. 162:1999;1331-1336.
3. Hart K.B., Wood D.P. Jr, Tekyi-Mensah S., et al. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy. Int J Radiat Oncol Biol Phys. 45:1999;1235-1238.
4. Iselin C.E., Box J.W., Vollmer R.T., et al. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer. 83:1998;2353-2360.
5. Eastham J.A., Kattan M.W. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol. 163:2000;143-145.
6. Freedland S.J., Jalkut M., Dorey F., et al. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 56:2000;87-91.
7. Bauer J.J., Connelly R.R., Seterhenn I.A., et al. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. J Urol. 159:1998;929-933.
8. Moul J.W., Douglas T.H., McCarthy W.F., et al. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 155:1996;1667-1673.
9. Powell I.J., Banerjee M., Novallo M., et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 55:2000;246-251.
10. Moul J.W., Connelly R.R., Lubeck D.P., et al. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol. 166:2001;1322-1327.
11. Tarman G.J., Kane C.J., Moul J.W., et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 56:2000;1016-1020.
12. Beahrs O.H., Henson D.E., Hutter R.V.P. American Joint Committee on Cancer Manual for Staging Cancer. 1992;JB Lippincott, Philadelphia.
13. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep. 50:1966;125-128.
14. Terris M.K. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer preliminary report . Urology. 54:1999;486-489.
15. Borirakchanyavat S., Bhargava V., Shinohara K., et al. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 50:1997;373-378.
16. Borboroglu P.G., Comer S.W., Riffenburgh R.H., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 163:2000;158-162.
17. http://www.census.gov/population/estimates/nation/intfile3-1.txt. Accessed November 4, 2001.